SOURCE: NewLink Genetics Corporation

September 05, 2013 07:00 ET

NewLink Genetics to Present at September Financial Conferences

AMES, IA--(Marketwired - Sep 5, 2013) - NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, announced today that NewLink management will present at the following financial conferences this month:

  • Baird 2013 Health Care Conference. The presentation will take place in New York on Tuesday, September 10, 2013 at 4:40 p.m. EDT.
  • Stifel Healthcare Conference 2013. The presentation will take place in Boston on Wednesday September 11, 2013 at 2:40 p.m. EDT. Interested parties may access a live webcast of the presentation by visiting the NewLink Genetics website at www.linkp.com. The webcast will be archived on the NewLink website following the event.
  • Newsmakers in the Biotech Industry 2013 Conference. The presentation will take place in New York on Friday, September 27, 2013 at 1:30 p.m. EDT. Interested parties may access a live webcast of the presentation by visiting the NewLink Genetics website at www.linkp.com. The webcast will be archived on the NewLink website following the event.

About NewLink Genetics Corporation

NewLink is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve treatment options for patients with cancer. NewLink's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. NewLink's product candidates are designed to harness multiple components of the immune system to combat cancer without significant incremental toxicity, either as a monotherapy or in combination with other treatment regimens. For more information please visit http://www.linkp.com. Patient information is available at http://www.pancreaticcancer-clinicaltrials.com.

Contact Information